FindTrial
Sign In

Diagnosis Of Chronic Obstructive Pulmonary Disease

A Study On Relationship Between High Resolution Computed Tomography Scoring,6 Minute Walk Test And GOLD (Global Initiative For Chronic Obstructive Lung Disease) Staging In A Case Of Chronic Obstructive Pulmonary Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055761
Enrollment
100
Registered
2023-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Aritra Sanyal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed to have COPD according to GOLD criteria â?? post-bronchodilator FEV ?/FVC 2.Patients clinically stable without baseline Oâ?? desaturation. 3.Patients having no history of acute exacerbation in the past 3 months. 4.Age â?? 40 to 80 years. 5.Total duration of illness â?? 1 to 30 years. 6.Patients giving informed consent to undergo study related testing.

Exclusion criteria

Exclusion criteria: 1.Unstable patient as per clinical assessment. 2.Patients with clinical, laboratory or radiological evidence of pneumonia, active pulmonary TB,bronchiectasis, cystic fibrosis, bronchogenic carcinoma, asthma or interstitial lung disease. 3.Patients with evidence of Heart Failure, acute myocardial infarction (AMI), congenital or valvular heart disease. 4.Patients with CVA, weakness of the lower limbs or peripheral vascular diseases. 5.Patients with BP > 180/110 mm Hg or Heart Rate > 140/min or Oxygen saturation (SpO2) 80% prior to 6 minute walk test. 6.Patients who are unwilling to undergo study related testing

Design outcomes

Primary

MeasureTime frame
1.To assess whether 6MWD correlates with the GOLD staging of COPD. 2.To assess whether visual scoring of emphysema on HRCT thorax correlates with the GOLD staging of COPD.Timepoint: 2 weeks,4 weeks,6 weeks—

Secondary

MeasureTime frame
To assess whether visual scoring of emphysema on HRCT thorax correlates with the 6MWD.Timepoint: 2 weeks,4 weeks,6 weeks—

Countries

India

Contacts

Public ContactDr Aritra Sanyal

Varun Arjun Medical College And Rohilkhand Hospital

respiratorymedicine34@gmail.com6399977870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026